デフォルト表紙
市場調査レポート
商品コード
1674049

動物用抗生物質の世界市場レポート 2025年

Veterinary Antibiotics Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
動物用抗生物質の世界市場レポート 2025年
出版日: 2025年03月03日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用抗生物質市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.9%で39億8,000万米ドルに成長します。予測期間の成長は、ペット保険の普及、ペット飼育率の上昇、政府イニシアチブの増加、動物の健康に関する意識の高まりに起因すると考えられます。予測期間の主な動向としては、戦略的提携やパートナーシップ、新しいチュアブル医薬品の開発、寄生虫駆除剤の配合、関節炎の新しい改良治療、動物ケア用ジェネリック医薬品の生産などが挙げられます。

動物用抗生物質市場は、人獣共通感染症の流行増加により成長を遂げています。人獣共通感染症は、動物と人間の間で感染する微生物、感染症、寄生虫によって引き起こされる感染症です。サルモネラやカンピロバクターといった一般的な人獣共通感染症病原体は、動物の腸内で発見され、食物連鎖を通じて人間に潜在的な脅威をもたらします。FoodNet(米国疾病予防管理センター)の調査によると、人獣共通感染症は食中毒24,484件、入院5,677件、死亡122件の原因となっています。これらの病気の人へのトランスミッションを防ぐために動物の早期診断が必要であることが、動物用抗生物質市場の重要な促進要因です。

ペット飼育率の増加が、今後数年間の動物用抗生物質市場の成長を促進すると予測されています。ペットの所有とは、法的に認められた責任ある行為であり、家畜を伴侶として世話をすることです。ペットの数が増加するにつれて、ペットの病気の治療と予防のための抗生物質の需要も増加し、健康と幸福を確保するために抗生物質を含む獣医学的治療を必要とする、より多くの患者を生み出すと予想されます。例えば、2024年10月の時点で、米国獣医師会(非営利の専門家団体)は、米国で犬を飼っている世帯の総数が5,980万世帯に達し、全世帯の45.5%を占めると予測していると報告しています。同様に、猫の飼育世帯数は4210万世帯に増加し、米国全世帯の32.1%を占める。その結果、ペット飼育数の増加が動物用抗生物質市場の拡大に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界動物用抗生物質PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界の動物用抗生物質市場:成長率分析
  • 世界の動物用抗生物質市場の実績:規模と成長, 2019-2024
  • 世界の動物用抗生物質市場の予測:規模と成長, 2024-2029, 2034F
  • 世界動物用抗生物質総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の動物用抗生物質市場:製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗寄生虫
  • 抗菌
  • 非ステロイド性抗炎症薬
  • その他の製品
  • 世界の動物用抗生物質市場管理による、実績と予測, 2019-2024, 2024-2029F, 2034F
  • プレミックス
  • 注射
  • 経口用粉末
  • 経口溶液
  • その他の管理
  • 世界の動物用抗生物質市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 農場の動物
  • コンパニオンアニマル
  • 世界の動物用抗生物質市場、抗寄生虫薬のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 内部寄生虫駆除剤
  • 外部寄生虫駆除剤
  • 世界の動物用抗生物質市場抗菌剤のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • テトラサイクリン
  • ペニシリン
  • マクロライド
  • アミノグリコシド
  • スルホンアミド
  • 世界の動物用抗生物質市場非ステロイド性抗炎症薬(NSAID)の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • カルプロフェン
  • メロキシカム
  • アスピリン
  • 世界の動物用抗生物質市場、その他、タイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 抗真菌
  • 抗ウィルス薬

第7章 地域別・国別分析

  • 世界の動物用抗生物質市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の動物用抗生物質市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 動物用抗生物質市場:競合情勢
  • 動物用抗生物質市場:企業プロファイル
    • Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
    • Zoetis, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co., Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • Vetoquinol S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Phibro Animal Health Corporation
  • Kyoritsu Seiyaku Corporation
  • Dechra Pharmaceuticals plc
  • Bayer Animal Health China
  • China Animal Healthcare Ltd.
  • China Animal Husbandry Industry Corporation Ltd.(CAHIC)
  • Guangdong Wens Dahuanong Biotechnology Co. Ltd.
  • IDEXX Laboratories
  • Merial Pulike Biological Engineering
  • Ceva Sante Animale
  • Nimrod Veterinary Products Ltd.
  • Bimeda
  • VIRBAC SA
  • Orion Animal Health
  • Laboratorios Calier, SA

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 動物用抗生物質市場2029:新たな機会を提供する国
  • 動物用抗生物質市場2029:新たな機会を提供するセグメント
  • 動物用抗生物質市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r26023

Veterinary antibiotics constitute a category of animal medications designed to combat infectious diseases in animals. They achieve this by eliminating microorganisms such as bacteria and parasites, hindering the growth of their cell walls to effectively combat infections and diseases in animals, thereby enhancing the health conditions of the animals.

The primary product types within veterinary antibiotics encompass anti-parasitic drugs, anti-bacterial medications, non-steroidal anti-inflammatory drugs (NSAIDs), and other related products. NSAIDs serve as a connection point between the production and activity of prostaglandins (enzymes) involved in inflammation. Approved veterinary NSAIDs find application in companion animal care, specifically in mitigating pain and swelling associated with osteoarthritis in dogs and horses. The administration of veterinary antibiotics includes various methods such as premixes, injections, oral powders, oral solutions, and other forms, catering to both farm animals and companion animals.

The veterinary antibiotics research report is one of a series of new reports from The Business Research Company that provides veterinary antibiotics statistics, including veterinary antibiotics industry global market size, regional shares, competitors with veterinary antibiotics share, detailed veterinary antibiotics segments, market trends and opportunities, and any further data you may need to thrive in the veterinary antibiotics industry. The veterinary antibiotics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary antibiotics market size has grown rapidly in recent years. It will grow from $2.47 billion in 2024 to $2.72 billion in 2025 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increased pet spending and shortages of generic medicines.

The veterinary antibiotics market size is expected to see strong growth in the next few years. It will grow to $3.98 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing penetration of pet insurance, rise in pet ownership, increase in government initiatives, and growing awareness about animal health. Major trends in the forecast period include strategic collaborations and partnerships, development of new chewable medicines, combination parasiticides, new improved treatments for arthritis and production of generic drugs for animal care.

The veterinary antibiotics market is experiencing growth due to an increase in the prevalence of zoonotic diseases. Zoonotic diseases are infectious conditions caused by microorganisms, infections, and parasites that can be transmitted between animals and humans. Common zoonotic pathogens such as salmonella and campylobacter, found in the intestines of animals, pose a potential threat to humans through the food chain. A study by FoodNet (Centers for Disease Control and Prevention, USA) revealed that zoonotic diseases cause 24,484 foodborne illnesses, 5,677 hospitalizations, and 122 deaths. The need for early diagnosis in animals to prevent the transmission of these diseases to humans is a significant driver of the veterinary antibiotics market.

The increasing rate of pet ownership is anticipated to drive the growth of the veterinary antibiotics market in the coming years. Pet ownership refers to the legally recognized and responsible practice of caring for domesticated animals as companions, which includes addressing their physical, emotional, and medical needs. As the number of pets grows, the demand for antibiotics to treat and prevent illnesses in pets is also expected to rise, creating a larger patient base that requires veterinary care, including antibiotics, to ensure their health and well-being. For example, as of October 2024, the American Veterinary Medical Association (a nonprofit professional association) reported that the total number of dog-owning households in the U.S. is projected to reach 59.8 million, representing 45.5% of all U.S. households. Similarly, the number of cat-owning households has increased to 42.1 million, accounting for 32.1% of all U.S. households. Consequently, the rise in pet ownership is fueling the expansion of the veterinary antibiotics market.

An emerging trend in the veterinary antibiotics market is the increasing collaboration between companies. Collaboration allows companies to combine technologies, diversify their product range, and enhance the quality and speed of antibiotic production. Notably, GlobalVetLink, a US-based provider of software services, collaborated with Veterinary Innovative Partners to implement the GlobalVetLink Compliance Assistant, a comprehensive SaaS platform simplifying animal health.

Major players in the veterinary antibiotics market are gaining a competitive edge by developing telemedicine platforms for pet healthcare. Telemedicine involves remote diagnosis, consultation, treatment, and monitoring of patients using telecommunications technology. Cargill Inc., a US-based food corporation, launched Zoonivet, a digital pet-care app in June 2023, facilitating pet healthcare through video calls, with plans to offer surgery, home diagnostic services, medication, pet food, and boarding in key Indian markets.

The veterinary antibiotics prescription drugs market operates under the regulatory framework of Section 503(f) of the Food, Drug, and Cosmetic Act by the FDA. This regulation mandates cautionary statements on veterinary antibiotic drug labels, emphasizing that these drugs can only be used with the permission of a licensed veterinarian. Stricter actions are taken against the sale and use of antibiotic prescription drugs without proper authorization, ensuring compliance with regulations governing veterinary antibiotic manufacturers and sellers.

Major companies operating in the veterinary antibiotics market include Boehringer Ingelheim GmbH, Zoetis, Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals plc, Bayer Animal Health China, China Animal Healthcare Ltd., China Animal Husbandry Industry Corporation Ltd. (CAHIC), Guangdong Wens Dahuanong Biotechnology Co. Ltd., IDEXX Laboratories, Merial Pulike Biological Engineering, Ceva Sante Animale, Nimrod Veterinary Products Ltd., Bimeda, VIRBAC SA, Orion Animal Health, Laboratorios Calier, SA, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Lamons Laboratories SA, SUPER'S DIANA, Swetrade Pharmaceuticals AB, Animalcare, VIC Animal Health, AVZ animal health, Provet Group, VitOMEK LCC, Micro-plus, Biowet, Bioveta, Brovapharma, Evrovet, Ukrvetprompostach, VELELEK d.o.o, Veterinarski Zavod Subotica, VetPlanet, Delos Medica, Vetro Solutions, Belfarmacom, IDT Biologika, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Saudi Pharmaceutical Industries (SPI), DBK Pharma S.A.E.

North America was the largest region in the veterinary antibiotics market in 2024. Asia-Pacific was the second-largest region in the global veterinary antibiotics market share. The regions covered in the veterinary antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary antibiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The veterinary antibiotics market consists of sales of antivirals, antiprotozoals, antifungals, aminoglycosides, beta-lactams, fluoroquinolones, glycopeptides, and lipopeptides. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Antibiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary antibiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary antibiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary antibiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others
  • 2) By End User: Farm Animals, Companion Animals
  • 3) By Administration: Premixes, Injections, Oral Powders, Oral Solutions, Others
  • Subsegments:
  • 1) Anti-Parasitic: Endoparasiticides; Ectoparasiticides
  • 2) Anti-Bacterial: Tetracyclines; Penicillins; Macrolides; Aminoglycosides; Sulfonamides
  • 3) Non-Steroidal Anti-Inflammatory Drug (Nsaid): Carprofen; Meloxicam; Aspirin
  • 4) Others: Antifungal; Antiviral
  • Companies Mentioned: Boehringer Ingelheim GmbH; Zoetis, Inc.; Merck & Co., Inc.; Elanco Animal Health Incorporated; Vetoquinol S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Antibiotics Market Characteristics

3. Veterinary Antibiotics Market Trends And Strategies

4. Veterinary Antibiotics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Veterinary Antibiotics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Veterinary Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Veterinary Antibiotics Market Growth Rate Analysis
  • 5.4. Global Veterinary Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Veterinary Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Veterinary Antibiotics Total Addressable Market (TAM)

6. Veterinary Antibiotics Market Segmentation

  • 6.1. Global Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Anti-Parasitic
  • Anti-Bacterial
  • Non-Steroidal Anti-Inflammatory Drug
  • Other Products
  • 6.2. Global Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Premixes
  • Injections
  • Oral Powders
  • Oral Solutions
  • Other Admisnistration
  • 6.3. Global Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Farm Animals
  • Companion Animals
  • 6.4. Global Veterinary Antibiotics Market, Sub-Segmentation Of Anti-parasitic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoparasiticides
  • Ectoparasiticides
  • 6.5. Global Veterinary Antibiotics Market, Sub-Segmentation Of Anti-bacterial, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Tetracyclines
  • Penicillins
  • Macrolides
  • Aminoglycosides
  • Sulfonamides
  • 6.6. Global Veterinary Antibiotics Market, Sub-Segmentation Of Non-steroidal Anti-inflammatory Drug (NSAID), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Carprofen
  • Meloxicam
  • Aspirin
  • 6.7. Global Veterinary Antibiotics Market, Sub-Segmentation Of Others, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Antifungal
  • Antiviral

7. Veterinary Antibiotics Market Regional And Country Analysis

  • 7.1. Global Veterinary Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Veterinary Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Antibiotics Market

  • 8.1. Asia-Pacific Veterinary Antibiotics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Antibiotics Market

  • 9.1. China Veterinary Antibiotics Market Overview
  • 9.2. China Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Antibiotics Market

  • 10.1. India Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Antibiotics Market

  • 11.1. Japan Veterinary Antibiotics Market Overview
  • 11.2. Japan Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Antibiotics Market

  • 12.1. Australia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Antibiotics Market

  • 13.1. Indonesia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Antibiotics Market

  • 14.1. South Korea Veterinary Antibiotics Market Overview
  • 14.2. South Korea Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Antibiotics Market

  • 15.1. Western Europe Veterinary Antibiotics Market Overview
  • 15.2. Western Europe Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Antibiotics Market

  • 16.1. UK Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Antibiotics Market

  • 17.1. Germany Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Antibiotics Market

  • 18.1. France Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Antibiotics Market

  • 19.1. Italy Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Antibiotics Market

  • 20.1. Spain Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Antibiotics Market

  • 21.1. Eastern Europe Veterinary Antibiotics Market Overview
  • 21.2. Eastern Europe Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Antibiotics Market

  • 22.1. Russia Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Antibiotics Market

  • 23.1. North America Veterinary Antibiotics Market Overview
  • 23.2. North America Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Antibiotics Market

  • 24.1. USA Veterinary Antibiotics Market Overview
  • 24.2. USA Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Antibiotics Market

  • 25.1. Canada Veterinary Antibiotics Market Overview
  • 25.2. Canada Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Antibiotics Market

  • 26.1. South America Veterinary Antibiotics Market Overview
  • 26.2. South America Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Antibiotics Market

  • 27.1. Brazil Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Antibiotics Market

  • 28.1. Middle East Veterinary Antibiotics Market Overview
  • 28.2. Middle East Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Antibiotics Market

  • 29.1. Africa Veterinary Antibiotics Market Overview
  • 29.2. Africa Veterinary Antibiotics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Veterinary Antibiotics Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Veterinary Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Antibiotics Market Competitive Landscape And Company Profiles

  • 30.1. Veterinary Antibiotics Market Competitive Landscape
  • 30.2. Veterinary Antibiotics Market Company Profiles
    • 30.2.1. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Zoetis, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co., Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Vetoquinol S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Antibiotics Market Other Major And Innovative Companies

  • 31.1. Phibro Animal Health Corporation
  • 31.2. Kyoritsu Seiyaku Corporation
  • 31.3. Dechra Pharmaceuticals plc
  • 31.4. Bayer Animal Health China
  • 31.5. China Animal Healthcare Ltd.
  • 31.6. China Animal Husbandry Industry Corporation Ltd. (CAHIC)
  • 31.7. Guangdong Wens Dahuanong Biotechnology Co. Ltd.
  • 31.8. IDEXX Laboratories
  • 31.9. Merial Pulike Biological Engineering
  • 31.10. Ceva Sante Animale
  • 31.11. Nimrod Veterinary Products Ltd.
  • 31.12. Bimeda
  • 31.13. VIRBAC SA
  • 31.14. Orion Animal Health
  • 31.15. Laboratorios Calier, SA

32. Global Veterinary Antibiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Antibiotics Market

34. Recent Developments In The Veterinary Antibiotics Market

35. Veterinary Antibiotics Market High Potential Countries, Segments and Strategies

  • 35.1 Veterinary Antibiotics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Veterinary Antibiotics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Veterinary Antibiotics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer